[
  {
    "ts": null,
    "headline": "AMG TimesSquare Small Cap Growth Fund Q1 2025 Commentary",
    "summary": "AMG TimesSquare Small Cap Growth Fund Q1 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=96514e00bbf051b224fa8528a502367da060b1d9afc56228846548140e450fd0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751065500,
      "headline": "AMG TimesSquare Small Cap Growth Fund Q1 2025 Commentary",
      "id": 135600760,
      "image": "",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=96514e00bbf051b224fa8528a502367da060b1d9afc56228846548140e450fd0"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Incorporated (VRTX) Benefited from the Launch of its New Drug",
    "summary": "Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, the Fund (Investor Shares) returned -8.59% (net of fees), outperforming the Russell 1000 Growth Index’s -9.97% decline. In the first quarter, post-election optimism, driven by […]",
    "url": "https://finnhub.io/api/news?id=f2acde4d5441e67c5a30401ab56015cadd961a3691a410870b823d512a4a57ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751030349,
      "headline": "Vertex Pharmaceuticals Incorporated (VRTX) Benefited from the Launch of its New Drug",
      "id": 135597090,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, the Fund (Investor Shares) returned -8.59% (net of fees), outperforming the Russell 1000 Growth Index’s -9.97% decline. In the first quarter, post-election optimism, driven by […]",
      "url": "https://finnhub.io/api/news?id=f2acde4d5441e67c5a30401ab56015cadd961a3691a410870b823d512a4a57ce"
    }
  }
]